loader
Please Wait
Applying Filters...
menu
    • menu

    List of Certificates of Suitability (CEPs) for Kenacort, Tri-Nasal, Triaderm, Azmacort, Triamcinolone Active Pharmaceutical Ingredient (API) issued by the EDQM. Original Data: EDQM Database

    Client Email Product
    2024 US Elections: Harris, Trump differ on abortion rights, ACA, public health spends; agree on need to cut drug prices

    Data Compilation
    #PharmaFlow

    Pipeline Prospector Sept 2024: BMS wins landmark FDA approval for schizophrenia med; Sanofi’s Dupixent okayed for COPD

    Stock Recap
    #PipelineProspector

    Menu

    Kenacort, Tri-Nasal, Triaderm, Azmacort, Triamcinolone

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    PRICE INFORMATION

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 1,694Xls download

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Data in the table can be downloaded after upgrading. In the meantime, you can access the data through the menu.

    Last Updated on PharmaCompass Virtual Booth Country Certificate Holder Certificate No. Substance Issue Date Status Type End Date Substance No.
    26/09/2024 Pfizer Inc
    U.S.A
    		 Pharmacia & Upjohn Company Kalamazoo US R0-CEP 2001-127 - Rev 00 Triamcinolone 5, (9beta,11beta-Epoxy-16alpha,17alpha,21-trihydroxypregna-1,4-diene-3,20-dione) 2002-04-09 Expired TSE 2007-04-09
    26/09/2024 Pfizer Inc
    U.S.A
    		 Pharmacia & Upjohn Company Kalamazoo US R0-CEP 2001-230 - Rev 00 Triamcinolone 3, (21-(acetyloxy)pregna-1,4,9(11)-16-tetraene-3,20-dione) 2002-04-09 Withdrawn by Holder TSE 2006-04-24